相关实验视频

Updated: Sep 10, 2025

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis

Published on: April 5, 2017

设计,合成和生物评估对结核病的库马林衍生物:基于药的方法

Suvaiv¹, Kuldeep Singh², Syed Misbahul Hasan¹

¹Faculty of Pharmacy, Integral University, Lucknow, UP, 226026, India.

Molecular diversity

|August 20, 2025

概括

新型库马林衍生物通过抑制Mycobacterium胺单酸激酶 (Mtb TMPK) 对抗耐药结核病具有强烈活性. 这些化合物为开发具有新型作用机制的新型结核病治疗提供了有希望的基础.

科学领域:

药用化学医学化学
药物发现药物发现药物发现
结核病研究结核病研究

背景情况:

结核病中药物耐药性的增加需要新的治疗策略.
耐药性,包括多耐药性和广泛耐药性菌株,构成了全球重大健康挑战.
迫切需要新的药物,具有新的作用机制,以对抗耐药结核病.

研究的目的:

探索针对结核病治疗的新型抑制剂Mycobacterium胺单酸激酶 (Mtb TMPK).
设计和选氨酸衍生物作为Mtb TMPK的潜在抑制剂.
识别和合成有前途的Mtb TMPK抑制剂,以提高疗效.

主要方法:

合理设计和选200种库马林衍生物对Mtb TMPK.
常见特征药模拟以确定关键的抑制性结构特征.
分子对接,ADMET分析,合成,以及使用REMA试验进行体外抗结核活性评估.

主要成果:

14种库马林-皮佩拉-乙胺衍生物被优先用于合成.
化合物S135,S144和S146在体外表现出强烈的抗结核活性,最小抑制度 (MIC) 为0.06μg/mL.
所有合成的化合物都表现出有前途的活性,MIC不超过1μg/mL,并且在体外表现出有利的细胞毒性概况.

结论:

针对Mtb TMPK的设计库马林类似物显示出作为新型抗结核剂的巨大潜力.
这些发现为开发克服现有的耐药机制的新结核病疗法提供了基础.
需要进一步的研究,重点是Mtb TMPK抑制试验,以确认作用模式,并将这些衍生品推向临床前开发.

关键词:

子二烯是一种子二烯.库马林是一种素.菌根细菌的胺单酸酶 (Mtb TMPK) 是一种制药类型的建模.结核病是一种疾病.

更多相关视频

A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis

A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis

Published on: March 24, 2017

Visualization of the Charcoal Agar Resazurin Assay for Semi-quantitative, Medium-throughput Enumeration of Mycobacteria

Visualization of the Charcoal Agar Resazurin Assay for Semi-quantitative, Medium-throughput Enumeration of Mycobacteria

Published on: December 14, 2016

相关概念视频

Structure-Activity Relationships and Drug Design

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...

Pulmonary Tuberculosis V

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...

Drug Discovery: Overview

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...